Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands
David Remillard(Dana-Farber Cancer Institute), James E. Bradner(Harvard University), Matthew Sonnett(Harvard University), Sirano Dhe‐Paganon(Neuroendocrine Tumor Research Foundation), Gerard L. Brien(Edinburgh Cancer Research), Scott A. Armstrong(Boston Children's Hospital), Shiva Dastjerdi(Dana-Farber Cancer Institute), Hyuk‐Soo Seo(Dana-Farber Cancer Institute), Dennis L. Buckley(Dana-Farber Cancer Institute), Martin Wühr(Princeton University), Joshiawa Paulk(Dana-Farber Cancer Institute)
Cited by 291